Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:GI

EndoChoice (GI) Stock Price, News & Analysis

EndoChoice logo

About EndoChoice Stock (NYSE:GI)

Advanced Chart

Key Stats

Today's Range
$8.00
$8.00
50-Day Range
N/A
52-Week Range
$3.64
$9.47
Volume
N/A
Average Volume
131,115 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

EndoChoice Holdings, Inc. is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems. The Company's products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The Company's imaging products include Fuse system, EndoCart, and Endoscope repair and maintenance. The Company's single-use therapeutic devices include Neptune injection needle, Boa polypectomy snare, Rescue retrieval devices, Blox bite block, TrapEase polyp traps, Hydra irrigation system, EndoGlide+, Compliance EndoKit, SafeStart, EndoKit, CinchPad and GI pathology. The Company serves over 2,500 GI departments that perform endoscopic procedures.

Receive GI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EndoChoice and its competitors with MarketBeat's FREE daily newsletter.

GI Stock News Headlines

Using Veterans Benefits to Pay for Grad School
F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.
See More Headlines

GI Stock Analysis - Frequently Asked Questions

EndoChoice Holdings Inc (NYSE:GI) issued its earnings results on Wednesday, May, 4th. The medical equipment provider reported ($0.68) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by $0.13. The firm's quarterly revenue was up 10.2% compared to the same quarter last year.

EndoChoice (GI) raised $101 million in an IPO on Friday, June 5th 2015. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, BofA Merrill Lynch, William Blair and Stifel served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that EndoChoice investors own include Cognyte Software (CGNT), Butterfly Network (BFLY), Coeur Mining (CDE), Denison Mines (DNN), DarioHealth (DRIO), CarParts.com (PRTS) and Air Canada (AC).

Company Calendar

Last Earnings
5/04/2016
Today
5/28/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:GI
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:GI) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners